The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
Oliver C CohenFaye SharpleyJanet A GilbertsonAshutosh D WechalekarSajitha SachchithananthamShameem MahmoodCarol J WhelanAna Martinez-NaharroMarianna FontanaHelen J LachmannPhilip N HawkinsJulian D GillmorePublished in: European journal of haematology (2020)
Performing both AFA and BM biopsy should be considered in suspected AL amyloidosis to substantially reduce the clinical risk associated with critical organ biopsy. The sensitivity of screening biopsies in ATTR amyloidosis is poor.